<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2696-130X</journal-id>
<journal-title><![CDATA[Revista mexicana de angiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. angiol.]]></abbrev-journal-title>
<issn>2696-130X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Angiología, Cirugía Vascular y Endovascular A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2696-130X2024000200059</article-id>
<article-id pub-id-type="doi">10.24875/rma.24000010</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo cardiovascular y su relación con la progresión de la enfermedad venosa crónica]]></article-title>
<article-title xml:lang="en"><![CDATA[Cardiovascular risk factors and their relationship with the progression of chronic venous disease]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Padilla-Hernández]]></surname>
<given-names><![CDATA[Leopoldo E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Hurtado]]></surname>
<given-names><![CDATA[Omar A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flores-Ramírez]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santoscoy-Ibarra]]></surname>
<given-names><![CDATA[Joaquín M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Enríquez-Sánchez]]></surname>
<given-names><![CDATA[Luis B.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hinojos-Flote]]></surname>
<given-names><![CDATA[Raúl A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Delgado-Ortega]]></surname>
<given-names><![CDATA[Dalia G.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carrasco-Arredondo]]></surname>
<given-names><![CDATA[Yarazi M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Central Universitario Dr. Jesús Enrique Grajeda Herrera Departamento de Angiología y Cirugía Vascular ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital General Salvador Zubirán Anchondo Departamento de Angiología y Cirugía Vascular ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Central Universitario Dr. Jesús Enrique Grajeda Herrera Departamento de Cirugía General ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2024</year>
</pub-date>
<volume>52</volume>
<numero>2</numero>
<fpage>59</fpage>
<lpage>64</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2696-130X2024000200059&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2696-130X2024000200059&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2696-130X2024000200059&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes: La progresión de la enfermedad venosa crónica (EVC) suele estar ligada a factores de riesgo que son motivo de investigación aun sin asociación clara.  Objetivo: Identificar si los factores de riesgo cardiovascular (FRC) impactan la progresión de la EVC.  Método: Análisis retrospectivo observacional de datos clínicos y epidemiológicos de 314 pacientes atendidos por el Servicio de Angiología y Cirugía Vascular del Hospital Central del Estado de Chihuahua de enero de 2021 a mayo de 2023.  Resultados: El grupo de edad más afectado por la EVC fue de los 52 a 61 años (27.1%), el 68.2% de los pacientes fueron mujeres, el 53.2% se identificó en estadio de insuficiencia venosa crónica (IVC), en una relación hombre-mujer de 28.7-71.3%. La presentación más frecuente fue C3 (30.6%). En el análisis de riesgo de los FRC, la ausencia de dislipidemia y tabaquismo representaron una reducción en la probabilidad de progresión de la EVC a IVC en un 35 y 34% respectivamente.  Conclusión: Esta revisión propone que algunos FRC podrían impactar en la progresión de la EVC hacia IVC.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background: The progression of chronic venous disease (CVD) is usually linked to risk factors that are the subject of research even without a clear association.  Objective: To identify whether cardiovascular risk factors (CRF) impact the progression of CVD.  Method: Retrospective observational analysis of clinical and epidemiological data of 314 patients treated by the Angiology and Vascular Surgery Service of the Central Hospital of the State of Chihuahua from January 2021 to May 2023.  Results: The most affected age group by CVD was 52 to 61 years (27.1%), 68.2% of patients were women, 53.2% were identified in the stage of chronic venous insufficiency (CVI), in a ratio of 28.7% men to 71.3%. women. The most frequent presentation was C3 (30.6%). In the CRF risk analysis, the absence of dyslipidemia and smoking represented a reduction in the probability of progression from CVD to CVI by 35 and 34% respectively.  Conclusion: This review proposes that some cardiovascular risk factors might impact the progression of CVD to CVI.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad venosa crónica]]></kwd>
<kwd lng="es"><![CDATA[Insuficiencia venosa crónica]]></kwd>
<kwd lng="es"><![CDATA[Factores de riesgo cardiovascular]]></kwd>
<kwd lng="en"><![CDATA[Chronic venous disease]]></kwd>
<kwd lng="en"><![CDATA[Chronic venous insufficiency]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular risk factors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Maeseneer]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Kakkos]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Aherne]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Baekgaard]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Black]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Blomgren]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editor's choice - European society for vascular surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2022</year>
<volume>63</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>184-267</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[LNG]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[QCL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de insuficiencia venosa en jóvenes universitarios y factores de riesgo correlacionados con el estadio clínico (CEAP c 1 y 2)]]></article-title>
<source><![CDATA[Dermatología Cosmética, Médica y Quirúrgica]]></source>
<year>2017</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>222-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sigler Morales]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda Gaxiola]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rish Fein]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insuficiencia venosa crónica en la República Mexicana]]></article-title>
<source><![CDATA[Rev Mex Angiol]]></source>
<year>2004</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>44-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raffetto]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiology of chronic venous disease and venous ulcers]]></article-title>
<source><![CDATA[Surg Clin North Am]]></source>
<year>2018</year>
<volume>98</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>337-47</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González-Ochoa]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de la enfermedad venosa crónica en México y su impacto en la calidad de vida]]></article-title>
<source><![CDATA[Rev Mex Angiol]]></source>
<year>2023</year>
<volume>51</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taengsakul]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for and treatment of chronic venous disease in Thai patients]]></article-title>
<source><![CDATA[Vasc Health Risk Manag]]></source>
<year>2022</year>
<volume>18</volume>
<page-range>667-76</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Labropoulos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How does chronic venous disease progress from the first symptoms to the advanced stages?A review]]></article-title>
<source><![CDATA[Adv Ther]]></source>
<year>2019</year>
<volume>36</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>13-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Velu]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Quigley]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Golledge]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of chronic venous disease with major adverse cardiovascular events]]></article-title>
<source><![CDATA[J Vasc Surg Venous Lymphat Disord]]></source>
<year>2022</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>683-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prochaska]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Falcke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kopp]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Buch]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic venous insufficiency, cardiovascular disease, and mortality:a population study]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2021</year>
<volume>42</volume>
<numero>40</numero>
<issue>40</issue>
<page-range>4157-65</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mansilha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2018</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1669</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The seriousness of chronic venous disease:A review of real-world evidence]]></article-title>
<source><![CDATA[Adv Ther]]></source>
<year>2019</year>
<volume>36</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>5-12</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Oropallo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic venous insufficiency:a comprehensive review of management]]></article-title>
<source><![CDATA[J Wound Care]]></source>
<year>2022</year>
<volume>31</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>510-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jaro&#353;íková]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rozto&#269;il]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Husáková]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dubský]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bém]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Wosková]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic venous disease and its intersections with diabetes mellitus]]></article-title>
<source><![CDATA[Physiol Res]]></source>
<year>2023</year>
<volume>72</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gourgou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lower limb venous insufficiency and tobacco smoking:A case-control study]]></article-title>
<source><![CDATA[Am J Epidemiol]]></source>
<year>2002</year>
<volume>155</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1007-15</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Babaei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Afrooghe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rafati]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mohebbi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Moosavi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ghadri]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and associated factors of chronic venous disease among the modern Iranian urban population]]></article-title>
<source><![CDATA[J Vasc Surg Venous Lymphat Disord]]></source>
<year>2023</year>
<volume>11</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1098-1106.e10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ielapi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Minici]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Peluso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bracale]]></surname>
<given-names><![CDATA[UM]]></given-names>
</name>
<name>
<surname><![CDATA[Andreucci]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for bleeding varicose veins in patients with chronic venous disease]]></article-title>
<source><![CDATA[Medicina (Kaunas)]]></source>
<year>2023</year>
<volume>59</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1034</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Png]]></surname>
<given-names><![CDATA[CYM]]></given-names>
</name>
<name>
<surname><![CDATA[Sumpio]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[DeCarlo]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Dua]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Defining the human and health care costs of chronic venous insufficiency]]></article-title>
<source><![CDATA[Semin Vasc Surg]]></source>
<year>2021</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>59-64</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Fraile-Martínez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[García-Montero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Mon]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Chaowen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Grande]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Understanding chronic venous disease:A critical overview of its pathophysiology and medical management]]></article-title>
<source><![CDATA[J Clin Med]]></source>
<year>2021</year>
<volume>10</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>3239</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gastaldi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pannier]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rozto&#269;il]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lugli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mansilha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Haller]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic venous disease and diabetic microangiopathy:pathophysiology and commonalities]]></article-title>
<source><![CDATA[Int Angiol]]></source>
<year>2021</year>
<volume>40</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kitchens]]></surname>
<given-names><![CDATA[BP]]></given-names>
</name>
<name>
<surname><![CDATA[Snyder]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cuffy]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A literature review of pharmacological agents to improve venous leg ulcer healing]]></article-title>
<source><![CDATA[Wounds]]></source>
<year>2020</year>
<volume>32</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>195-207</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
